Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis

BackgroundImmune checkpoint inhibitors (ICIs) have achieved acknowledged progress in cancer therapy. However, ICI-associated cardiotoxicity as one of the most severe adverse events is potentially life-threatening, with limited real-world studies reporting its predictive factors and prognosis. This s...

Full description

Bibliographic Details
Main Authors: Xue Chen, Aimin Jiang, Rui Zhang, Xiao Fu, Na Liu, Chuchu Shi, Jingjing Wang, Xiaoqiang Zheng, Tao Tian, Xuan Liang, Zhiping Ruan, Yu Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
solid tumor
cardiotoxicity
rechallenge
risk factors
immune checkpoint inhibitor (ICI)
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.882167/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.882167/full

Similar Items